Outlook Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Outlook Wealth Advisors's PFE Position: Q1 2023 in Review
Outlook Wealth Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,418 shares — an estimated $226K sold.
Outlook Wealth Advisors first reported a position in PFE in Q4 2018 and held it in 14 quarters. The position peaked at $547K in Q4 2018. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Outlook Wealth Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- Outlook Wealth Advisors sold 4,418 Pfizer shares in Q1 2023, an estimated $226K.
- Outlook Wealth Advisors first reported a position in Pfizer in Q4 2018 and held it in 14 quarters.
- Outlook Wealth Advisors's Pfizer position peaked at $547K in Q4 2018.
- 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Outlook Wealth Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.